Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value-A Multicenter Study From South India.
Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Kumar S, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS, Nandennavar M, Murugesan J, Patil CN, Anoop P, Jacob RK, Kalashetty M, Rathnam K, Ganapathy R.
Karpurmath SV, et al. Among authors: reddy k, reddy n.
Clin Lymphoma Myeloma Leuk. 2020 May;20(5):e205-e211. doi: 10.1016/j.clml.2019.09.606. Epub 2019 Sep 30.
Clin Lymphoma Myeloma Leuk. 2020.
PMID: 32146105